Skip to main content

Table 5 NT-proBNP concentrations in pmol/L for the respective groups at baseline and follow-up examination

From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

Groups

Baseline (n; median [IQR])

Follow-up (n; median [IQR])

P-value

Control

19; 501 [298–898]

15; 434 [301–735]

NS

Stage B1

41; 541 [389–955]

33; 636 [412–859]

0.0113*

Stage B2

9; 423 [332–1763]

12; 952 [537–1828]

NS

Stage C

14; 3876 [1192–4563]

6; 1247 [2483–4353]

NS

  1. IQR Interquartile range, NS Non-significant. Data are presented as median (IQR). The p-value denotes the probability of the change in NT-proBNP concentrations from baseline to follow-up examination for each group. * p < 0.05